Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world multicenter open-label study of Anjianning (adalimumab) in children with severe psoriasis
CTR20252419Phase 4Active
- Sponsor
- BioRay Pharmaceutical Co., Ltd.
- Start
- Jul 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in plaque psoriasis, psoriasis, sponsored by BioRay Pharmaceutical Co., Ltd.. Started Jul 2025; status: active.
02
Drugs
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on CTR20252419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252419.